RNAi治療薬の世界市場は、2024年から2028年にかけて10.02%のCAGRで成長し、2028年には12億6,000万ドルに達する見込みです。医薬品の利用率の上昇、感染症の蔓延の加速、高齢人口の増加、神経変性疾患の有病率の増加、RNAi治療薬の共同研究および関連取引の進展などが市場の成長要因です。しかし、RNAi治療薬の薬物送達に関連する複雑さ、RNA干渉ベースの治療薬の高い開発コスト、および厳しい規制要件が課題となります。いくつかの注目すべき動向としては、個別化医療の人気の高まり、HTSおよびケロイド治療の代替としてのRNAi治療薬の選好の高まり、分子診断における用途の拡大などがあります。
世界市場は、分子の種類、用途、エンドユーザー別に分類されています。分子の種類別に、世界市場は低分子干渉RNA (siRNA) とマイクロRNA (miRNA) に分かれます。用途に応じて、市場は腫瘍学、呼吸器疾患、神経疾患、肝疾患、自己免疫疾患、その他の疾患に分けることができます。一方、世界のRNAi治療薬市場は、エンドユーザーの観点から、研究および学術研究所と病院および診断研究所に分けられます。
慢性疾患の有病率の増加、RNAi治療薬の開発への投資の増加、およびこの地域でのRNAベースの治療薬の研究活動の増加によって、最も急速に成長している地域市場は北米です。さらに、COVID-19のパンデミックは、RNAベースの研究の関連性の高まりや研究開発活動への資金提供の増加により、市場にプラスの影響を与えています。
目次
Table of contents
1. Market Overview
1.1 Introduction
1.2 Different Classes of RNA Therapeutics
1.3 Major Pathways of RNAi
1.4 Various Small RNA Isoforms related to RNAi
1.5 Key Features of RNAi Therapeutics
1.6 Comparison of RNAi Treatments against Other Treatment Classes
1.7 Platform Comparison of RNAi Therapeutics
1.8 Applications of RNAi in Vivo
2. Impact of COVID-19
2.1 Rapid Spread of Coronavirus
2.2 Growth in COVID-19 R&D Funding
2.3 RNA Vaccine Development for COVID-19
3. Global Market Analysis
3.1 Global RNAi Therapeutics Market by Value
3.2 Global RNAi Therapeutics Market Forecast by Value
3.3 Global RNAi Therapeutics Market by Molecule Type
3.3.1 Global Small Interfering RNA (siRNA) Therapeutics Market by Value
3.3.2 Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Value
3.3.3 Global Small Interfering RNA (siRNA) Therapeutics Market by Type
3.3.4 Global Small Interfering RNA (siRNA) Therapeutics Type Market by Value
3.3.5 Global Small Interfering RNA (siRNA) Therapeutics Type Market Forecast by Value
3.3.6 Global MicroRNA (miRNA) Therapeutics Market by Value
3.3.7 Global MicroRNA (miRNA) Therapeutics Market Forecast by Value
3.4 Global RNAi Therapeutics Market by Application
3.4.1 Global RNAi Therapeutics Application Market by Value
3.4.2 Global RNAi Therapeutics Product Market Forecast by Value
3.5 Global RNAi Therapeutics Market by End-Users
3.5.1 Global RNAi Therapeutics End-User Market by Value
3.5.2 Global RNAi Therapeutics End-User Market Forecast by Value
3.6 Global RNAi Therapeutics Market by Region
4. Regional Market Analysis
4.1 North America
4.1.1 North America RNAi Therapeutics Market by Value
4.1.2 North America RNAi Therapeutics Market Forecast by Value
4.1.3 The U.S. RNAi Therapeutics Market Forecast by Value
4.2 Europe
4.2.1 Europe RNAi Therapeutics Market by Value
4.2.2 Europe RNAi Therapeutics Market Forecast by Value
4.3 Asia Pacific
4.3.1 Asia Pacific RNAi Therapeutics Market by Value
4.3.2 Asia Pacific RNAi Therapeutics Market Forecast by Value
4.4 RoW
4.4.1 RoW RNAi Therapeutics Market by Value
4.4.2 RoW RNAi Therapeutics Market Forecast by Value
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Rising Utilization in Oncology Pharmaceuticals
5.1.2 Accelerating Growth Rates of Infectious Diseases
5.1.3 Enlarging Geriatric Population
5.1.4 Increasing Prevalence of Neurodegenerative Disorders
5.1.5 Progress in Collaborations & Associated Deals in RNAi Therapeutics
5.1.6 Expanding Research & Development Activities
5.2 Key Trends and Developments
5.2.1 Growing Popularity of Personalized Medicine
5.2.2 Surging Preference as an Alternative for HTS & Keloids Treatment
5.2.3 Escalating Applications in Molecular Diagnostics
5.2.4 Development of RNAi Therapeutics
5.3 Challenges
5.3.1 Complexity Associated with the Delivery of RNAi Therapeutics
5.3.2 High Development Cost of RNA Interference-Based Therapeutics
5.3.3 Stringent Regulatory Requirements
6. Company Profiles
6.1 Sanofi S.A. (Genzyme Corporation)
6.1.1 Business Overview
6.2 Alnylam Pharmaceuticals Inc.
6.2.1 Business Overview
6.3 Arrowhead Pharmaceuticals Inc.
6.3.1 Business Overview
6.4 Arbutus Biopharma Corporation
6.4.1 Business Overview
6.5 Benitec Biopharma Ltd.
6.5.1 Business Overview
6.6 Sirnaomics, Ltd.
6.6.1 Business Overview
List of Figures
Schematic Illustration of Different Classes of RNA Therapeutics
RNA Interference Therapeutic Process
Various Small RNA Isoforms related to RNAi
Key Features of RNAi Therapeutics
Applications of RNAi in Vivo
Number of Cumulative Cases of Coronavirus (COVID-19) Worldwide (2020)
Global RNAi Therapeutics Market by Value (2019-2023)
Global RNAi Therapeutics Market Forecast by Value (2024-2028)
Global RNAi Therapeutics Market by Molecule Type (2023)
Global Small Interfering RNA (siRNA) Therapeutics Market by Value (2019-2023)
Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Value (2024-2028)
Global Small Interfering RNA (siRNA) Therapeutics Market by Type (2023)
Global Small Interfering RNA (siRNA) Therapeutics Type Market by Value (2019-2023)
Global Small Interfering RNA (siRNA) Therapeutics Type Market Forecast by Value (2024-2028)
Global MicroRNA (miRNA) Therapeutics Market by Value (2019-2023)
Global MicroRNA (miRNA) Therapeutics Market Forecast by Value (2024-2028)
Global RNAi Therapeutics Market by Application (2023)
Global RNAi Therapeutics Application Market by Value (2019-2023)
Global RNAi Therapeutics Product Market Forecast by Value (2024-2028)
Global RNAi Therapeutics Market by End-Users (2023)
Global RNAi Therapeutics End-User Market by Value (2019-2023)
Global RNAi Therapeutics End-User Market Forecast by Value (2024-2028)
Global RNAi Therapeutics Market by Region (2023)
North America RNAi Therapeutics Market by Value (2019-2023)
North America RNAi Therapeutics Market Forecast by Value (2024-2028)
The U.S. RNAi Therapeutics Market Forecast by Value (2020-2028)
Europe RNAi Therapeutics Market by Value (2019-2023)
Europe RNAi Therapeutics Market Forecast by Value (2024-2028)
Asia Pacific RNAi Therapeutics Market by Value (2019-2023)
Asia Pacific RNAi Therapeutics Market Forecast by Value (2024-2028)
RoW RNAi Therapeutics Market by Value (2019-2023)
RoW RNAi Therapeutics Market Forecast by Value (2024-2028)
Oncology Pharmaceuticals Market in the U.S. and China (2020-2030)
Global Growth Rate of Infectious Diseases Forecast (2017-2023)
Global Population 65 Years and Above (2017-2023)
Worldwide Projections of Alzheimer’s Disease Prevalence (2015-2040)
Global Personalized Medicine Market (2018-2023)
Market Size of Hypertrophic Scars (HTS) & Keloids Treatments (2020-2030)
Global Molecular Diagnostics Market (2021-2026)
List of Tables
Comparison of RNAi Treatments against Other Treatment Classes
Platform Comparison of RNAi Therapeutics
COVID-19 R&D Funding by Major Countries (2020)
mRNA Vaccine in Development for COVID-19
Deals in RNAi Therapeutics (2020-2023)
Approved RNAi Therapeutics (2019-2023)
